Login / Signup

Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands.

Agnes C KantJurriaan JansenLeontine van BalverenFlorence P A M van Hunsel
Published in: Drug safety (2022)
The analysis of a large cohort provides important information about the rates of AEFIs across age groups, among brands of vaccines and between those with and without prior COVID-19 infection. Participants reported a high number of AEFIs in general, but the frequency of serious AEFIs was low.
Keyphrases
  • coronavirus disease
  • sars cov
  • health information
  • healthcare
  • respiratory syndrome coronavirus